Sandra J van Vliet
Overview
Explore the profile of Sandra J van Vliet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
3886
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
van Spronsen M, Horrevorts S, Cali C, Westers T, Van Gassen S, Saeys Y, et al.
Leukemia
. 2023 Feb;
37(3):702-707.
PMID: 36759685
No abstract available.
12.
da Costa V, Marino K, Rodriguez-Zraquia S, Festari M, Lores P, Costa M, et al.
Int J Mol Sci
. 2022 Oct;
23(19).
PMID: 36233358
Lung cancer is the first leading cause of cancer-related deaths in the world. Aberrant glycosylation in lung tumors leads to the expression of tumor-associated carbohydrate structures, such as the Tn...
13.
Lubbers J, Eveline Li R, Gorki F, Bruijns S, Gallagher A, Kalay H, et al.
Immunother Adv
. 2022 Aug;
1(1):ltab012.
PMID: 35919745
Objective: We here investigated whether α2-3sia, that bind immune inhibitory Siglec receptors, would alter signaling and reprogramming of LPS-stimulated human monocyte-derived DCs (moDCs). Methods And Results: Transcriptomic analysis of moDCs...
14.
Rodriguez E, Boelaars K, Brown K, Madunic K, van Ee T, Dijk F, et al.
Commun Biol
. 2022 Jan;
5(1):41.
PMID: 35017635
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most aggressive malignancies with a 5-year survival rate of only 9%. Despite the fact that changes in glycosylation patterns during tumour progression...
15.
da Costa V, van Vliet S, Carasi P, Frigerio S, Garcia P, Croci D, et al.
Cancer Lett
. 2021 Jun;
518:72-81.
PMID: 34144098
Tn is a tumor-associated carbohydrate antigen that constitutes both a diagnostic tool and an immunotherapeutic target. It originates from interruption of the mucin O-glycosylation pathway through defects involving, at least...
16.
Stolk D, Horrevorts S, Schetters S, Kruijssen L, Duinkerken S, Keuning E, et al.
Mol Ther Oncolytics
. 2021 Jun;
21:315-328.
PMID: 34141869
Induction of tumor-specific cytotoxic CD8 T cells (CTLs) via immunization relies on the presentation of tumor-associated peptides in major histocompatibility complex (MHC) class I molecules by dendritic cells (DCs). To...
17.
Eveline Li R, de Haas A, Rodriguez E, Kalay H, Zaal A, Jimenez C, et al.
Front Immunol
. 2021 May;
12:673454.
PMID: 33968084
Dendritic cells (DCs) are key initiators of the adaptive immunity, and upon recognition of pathogens are able to skew T cell differentiation to elicit appropriate responses. DCs possess this extraordinary...
18.
Anderluh M, Berti F, Bzducha-Wrobel A, Chiodo F, Colombo C, Compostella F, et al.
FEBS J
. 2021 May;
289(14):4251-4303.
PMID: 33934527
Vaccination is one of the greatest achievements in biomedical research preventing death and morbidity in many infectious diseases through the induction of pathogen-specific humoral and cellular immune responses. Currently, no...
19.
Anderluh M, Berti F, Bzducha-Wrobel A, Chiodo F, Colombo C, Compostella F, et al.
FEBS J
. 2021 Mar;
288(16):4746-4772.
PMID: 33752265
Glycan structures are common posttranslational modifications of proteins, which serve multiple important structural roles (for instance in protein folding), but also are crucial participants in cell-cell communications and in the...
20.
Rodriguez E, Boelaars K, Brown K, Li R, Kruijssen L, Bruijns S, et al.
Nat Commun
. 2021 Feb;
12(1):1270.
PMID: 33627655
Changes in glycosylation during tumour progression are a key hallmark of cancer. One of the glycan moieties generally overexpressed in cancer are sialic acids, which can induce immunomodulatory properties via...